Amgen is a well known pharmaceutical manufactured by GlaxoSmithKline. Their product, which is marketed under several names, is used for the treatment of allergies and hair loss. In January 2021, GlaxoSmithKline recalled the drug Amgen due to reports of a possible link to breast cancer. This article discusses the recalls and other information relating to this issue.
A number of lawsuits have been filed against GlaxoSmithKline. One such lawsuit was filed by J. Stephen Lanning, who is the co-author of Nausea and Losses: Inside Secrets of Finding Your Pain Relief, an eBook that was designed to help those who have had chemotherapy experience nausea, vomiting, dizziness, headaches, fatigue, and loss of appetite. He is a member of the Physicians and Human Rights Association. According to the FDA, Amgen was sold to certain patients without verifying the doctor’s credentials.
In February, J. Stephen Lanning filed suit against Amgen, claiming that he developed respiratory problems while using their product. The company’s stock price dropped by forty percent in a matter of days as a result of the lawsuit. In May, the U.S. Federal Trade Commission fined GlaxoSmithKline $47 million for the recall and for failing to provide customer support.
There are a number of lawsuits that have been filed against Amgen. Some of those who have filed suits are from the state of California, where Amgen is based; others are from the District of Columbia, Maryland, and from New York City itself. One of the plaintiffs in the New York lawsuit is seeking compensation for the suffering caused by the negligence of GlaxoSmithKline. She is seeking compensatory and/or future financial losses, permanent physical impairment, permanent disability, and an additional amount for pain and suffering.
No settlement has been reached as of this writing. Amgen has denied any liability. An attorney who is not associated with GlaxoSmithKline is working on the case pro Bono. No judge or jury has ever ordered GlaxoSmithKline to pay compensatory damages in a lawsuit. The company has settled out of court a few times, usually settling out of court with either no admission of guilt or with very limited admission of guilt.
GlaxoSmithKline has settled out of court with plaintiffs who have been awarded millions of dollars. In one case, the company has agreed to settle out of court for less than a billion dollars. This may not seem like much, but when you add up all of the money they have lost due to lawsuits and the money they will lose because of the new settlements, it becomes clear that a huge loss is occurring for GlaxoSmithKline. Many of the victims of these injuries are still experiencing medical issues as a result of their injuries. In a case like this, a lawyer who is well experienced and well known is needed in order to represent the victim properly so that justice can be seen for all to see.